FOCAD and cancer: We found that miR-491-5p could be an intronic miRNA processed from FOCAD gene and first indicated that FOCAD/miR-491-5p inhibit cancer stemness, EMT, drug resistance, cell migration and invasion as well as pulmonary metastasis etc. in TNBC.